WA Business News subscriber login

pSivida completes recruitment stage of BrachySil trials
13-August-07
Written by Edited announcement

Perth-headquartered bio-nanotech company pSivida Ltd has completed the recruitment stage of the second phase of a clinical study of cancer treatment technology BrachySil in the treatment of inoperable pancreatic cancer.

BrachySil is a modified form orf silicon used by the company to deliver a therapeutic directly to solid tumours.

The study took place in hospitals in the United Kingdom and Singapore.

The full text of a company announcement is pasted below

Article continues...

Welcome to the new WA Business News website.

We invite you to explore our new site, with its added features and tools. The search capabilities of archives has been upgraded and expanded, includes 17,546 Western Australian business articles totalling 6,497,223 words.

Subscribers to the WA Business News are able to access articles as part of their subscription. If you are not a subscriber you can subscribe online now or you can purchase credits to view the articles. Alternatively you can also request an 8 week free trial of our paper (Note: the 8 week trial does not include website access).

If you are a subscriber or have previously registered with the website and don't know your login details please contact us on +61 8 9288 2100. If you are unsure of your login password please complete the forgot password form

Kind regards

Harry Kleyn - Publisher

TO-DO LIST

> 40under40 nomination
> Sign up for a subscription
> Sign up for our daily alerts
> Send in a media release

SUBSCRIBE TODAY!